PROM1 and glioblastoma: Two distinct patient-derived heterogeneous GBM cell lines were characterized by flow cytometry into non-stem-like CD133/PROM1LOW and stem cell-like CD133/PROM1HIGH subpopulations (Fig. 1b; Additional file 1: Figure 1A).